This article is more than 5 years old. Information may no longer be current.

US surgeons now implanting Visian toric ICL

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical announced the first U.S. patients have been implanted with the Visian toric ICL after its FDA approval in September.

The procedures were performed at Brinton Vision in St. Louis and Parkhurst NuVision in San Antonio on Oct. 22. The lens has been available outside of the U.S. since 2002, according to a press release.

The lens is indicated for patients between 21 and 45 years of age for the correction of myopic astigmatism with spherical equivalent ranging from –3 D to –15 D and cylinder of 1 D to 4 D in the spectacle plane.

Both patients have had good outcomes and are no longer dependent on glasses, the release said.

“The first toric implants in the U.S. represent the initial steps in onboarding surgeons as we introduce this lens to more than 50 U.S. markets in the coming months,” Caren Mason, STAAR president and CEO, said in the release.